Linked Life Data

9289703

Source:http://linkedlifedata.com/resource/pubmed/id/9289703

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19-22
pubmed:dateCreated
1997-9-5
pubmed:abstractText
Among 82 patients with L-LP in clinical stage IV, 14% were found to have monoclonal gammapathy and 22% polyclonal gammapathy. The other classes of immunoglobulins were not affected. In 78%, cell immunity was impaired. Decrease in T cell count (CD2+ and CD3+) in blood was found. Particularly T helper cells (CD4+), to a lesser degree T suppressor cells (CD8+) were affected. The life time of patients varied from 3 to 120 months. 60% of deaths were caused by infection.
pubmed:language
pol
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0032-3756
pubmed:author
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
260-2
pubmed:dateRevised
2008-6-20
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
[Lymphoplasmacytoid lymphoma and the immune system in patients with this type of lymphoma].
pubmed:affiliation
Kliniki Hematologii AM w Warszawie.
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract, Controlled Clinical Trial